The DBH-AS1, FLVCR1-DT, and NCBP2AS2-1 RNAs showed significantly higher levels in patients with moderate COVID-19 infection than controls, while patients with severe infection had significantly higher levels than both controls and patients with moderate infection (p =< 0.001 for all). This evidence concerns the gene DBH and infection.